Leukaemia risk in Crohn's disease [16]

Lancet

Volumn 347, Issue 9007, 1996, Pages 1049-1050

  Hatake, K ^a   Tanaka, M ^a   Muroi, K ^a   Miura, Y ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; AZATHIOPRINE; CORTICOSTEROID; DAUNORUBICIN; IMMUNOSUPPRESSIVE AGENT; MERCAPTOPURINE; PREDNISOLONE; SALAZOSULFAPYRIDINE; VINCRISTINE;

ADULT; BASAL CELL CARCINOMA; BRAIN LYMPHOMA; CANCER RISK; CASE REPORT; COLON RESECTION; CROHN DISEASE; DISEASE ASSOCIATION; HUMAN; KIDNEY CARCINOMA; LETTER; LEUKEMIA; MALE; MELANOMA; PANCYTOPENIA; PRIORITY JOURNAL; REMISSION;

EID: 0029986036     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)90191-9     Document Type: Letter

References (5)

1. Y. Bouhnik M. Lémann J-Y. Mary Long-term follow up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine Lancet 347 1996 215 219
2. Ja Giron M. Yepra Jj Solovera Crohn's disease and leukemia Dig Dis Sci 30 1985 410 411
3. Em Cohn B. Pearlstine Inflammatory bowel disease and leukemia J Clin Gastroenterol 6 1984 33 35
4. L. Halmes J. Knorring E. Elonen Development of acute myelocytic leukemia in patients with Crohn's disease Dig Dis Sci 35 1990 1553 1556
5. S. Orii T. Sugai O. Nakano O. Yoshinari S. Sato Acute promyelocytic leukemia in Crohn's disease Case report and review of the literature. J Clin Gastroenterol 13 1991 325 327